Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Cycle: Exhalation

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Antiasthma Drugs: β2-Adrenoceptor Agonists

Antiasthma Drugs: β₂-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Obesity in adults with cystic fibrosis following prescription of elexacaftor/tezacaftor/ivacaftor.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026

Same author

Health disparities in cystic fibrosis in the context of the exposome: recent developments and future directions.

Expert review of respiratory medicine·2026

Same author

Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) in People with Cystic Fibrosis in the United States.

Annals of the American Thoracic Society·2026

Same author

The Human Cost of Respiratory Care: Professional Quality of Life and Burnout Across Multidisciplinary Cystic Fibrosis Teams.

Chest·2026

Same author

What was that you said?

Paediatric respiratory reviews·2026

Same author

Stakeholder Priorities for Cystic Fibrosis Mental Health Research: A Community and Provider Survey.

Pediatric pulmonology·2026

Search research articles

Related Experiment Video

Updated: Aug 24, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Bronchiolitis therapies and misadventures.

Rosalie S N Linssen¹, Michael S Schechter², Bruce K Rubin²

¹Amsterdam University Medical Center, Location AMC, Meibergdreef 9, 1105AZ Amsterdam, the Netherlands.

Paediatric Respiratory Reviews

|October 24, 2022

Summary

This summary is machine-generated.

Respiratory syncytial virus (RSV) causes bronchiolitis in young children, with supportive care remaining the primary treatment. Future research should explore varied age groups and subgroups for effective bronchiolitis therapies.

Keywords:

Bronchiolitis Outcomes Treatment

More Related Videos

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Aug 24, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

Area of Science:

Pediatrics
Infectious Diseases
Pulmonology

Background:

Bronchiolitis, primarily caused by respiratory syncytial virus (RSV), is a common respiratory illness in infants and young children.
Current management for bronchiolitis relies exclusively on supportive care, lacking targeted antiviral or anti-inflammatory treatments.
Despite extensive research, effective pharmacological interventions for bronchiolitis remain elusive.

Purpose of the Study:

To review the historical progression of bronchiolitis treatments, including those that were unsuccessful.
To examine novel and emerging therapies currently under investigation for managing bronchiolitis.
To highlight the need for stratified approaches in future clinical trials.

Main Methods:

Systematic review of published literature on bronchiolitis treatments.
Analysis of historical treatment strategies and their outcomes.
Evaluation of ongoing clinical trials for new bronchiolitis therapies.

Main Results:

Many previously investigated treatments for bronchiolitis have proven ineffective.
Several new therapeutic agents are in various stages of clinical development.
Treatment responses may vary significantly across different pediatric subgroups.

Conclusions:

Supportive care continues to be the cornerstone of bronchiolitis management.
Future research must investigate treatments considering age, prior wheezing history, family asthma history, and non-RSV viral causes.
Personalized treatment strategies are crucial for optimizing outcomes in pediatric bronchiolitis.